GlassScriptPhysician profile
Fran Brandt
NPI 1962966374
$4,828.49
in general payments reported to CMS, 2019-2025
31 companies · $435 in 2025
The $435 reported for 2025 was more than what 77% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $1,676 · 2023: $2,131 · 2024: $484 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,049.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,759.32 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Abbott Laboratories | $1,121.29 | 2023 | Proclaim |
| Baxter Healthcare | $379.30 | 2022-2025 | Floseal, Tisseel, Perclot |
| Si-Bone, INC. | $285.80 | 2024-2025 | |
| Abbvie INC. | $245.18 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $122.55 | 2022 | |
| Genentech USA, INC. | $103.49 | 2021-2023 | Ocrevus, Evrysdi |
| Alexion Pharmaceuticals, INC. | $101.69 | 2022-2023 | Ultomiris, Soliris |
| Takeda Pharmaceuticals U.S.A., INC. | $84.46 | 2022-2023 | Gammagard |
| Getinge USA Sales, LLC | $81.41 | 2023 | Vasoview Hemopro 2 |
| Acorda Therapeutics, INC | $64.94 | 2023 | Inbrija |
| Carlsmed, INC. | $64.71 | 2022-2023 | Aprevo |
| Neurelis, INC. | $50.25 | 2023 | Valtoco |
| Stryker Corporation | $33.08 | 2025 | Mild Device Kit |
| Omniscient Neurotechnology America LTD | $26.19 | 2023 | Quicktome |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $25.00 | 2023 | |
| Orthofix Medical, INC. | $24.78 | 2025 | Firebird Si Navigation System |
| Merz Pharmaceuticals, LLC | $24.40 | 2023 | Xeomin |
| Emd Serono, INC. | $24.31 | 2023 | Mavenclad |
| Ethicon US, LLC | $23.41 | 2025 | Vistaseal, Stratafix |
| Otsuka America Pharmaceutical, INC. | $22.21 | 2023 | Nuedexta |
| Lundbeck LLC | $20.09 | 2023 | Vyepti |
| Janssen Pharmaceuticals, INC | $18.60 | 2023 | Xarelto |
| Arteriocyte Medical Systems, INC. | $17.55 | 2023 | Magellan |
| Teva Pharmaceuticals USA, INC. | $17.39 | 2023 | Austedo Xr |
| Argenx US, INC. | $16.97 | 2022 | |
| Lilly USA, LLC | $16.84 | 2023 | Amyvid |
| Impel Pharmaceuticals INC. | $14.28 | 2023 | Trudhesa |
| Integra Lifesciences Corporation | $13.78 | 2025 | Codman Hakim, Cusa Clarity, Codman Certas |
| Curonix LLC | $13.24 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Astrazeneca Pharmaceuticals LP | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fran Brandt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.